Skip to main content
Fig. 3 | Translational Medicine Communications

Fig. 3

From: A practical prognostic lncRNA signature for lung squamous cell carcinoma

Fig. 3

Kaplan-Meier and ROC curves for the 7-lncRNA signature in the validation set. a The differences between the high-risk (n = 103) and low-risk (n = 91) groups were determined by the log-rank test (p < 0.0001). Five year overall survival was 36.8% (95% CI: 26.1%-51.8%) and 61.9% (95% CI: 51.4%-74.6%) for the high-risk and low-risk groups, respectively. b ROC curves indicated that the area under receiver operating characteristic of 7-lncRNA model was 0.685

Back to article page